Citing ‘exorbitant prices,’ Trump demands control of Panama Canal be returned to U.S.
President-elect Donald Trump threatened Sunday to demand control of the Panama Canal be returned to the United States, and went
Archive for 2024
Read More »
Mirage News
12:20
AFP, ABF Crack Down on Fridge Containers Post Coke Bust | Mirage News
The AFP has identified a recent trend which has resulted in the seizure of over one tonne of cocaine hidden
Stuff sports reporters
12:20
Live: White Ferns struggling in pursuit of Australia’s 290
A first win over Australia in 14 meetings is potentially needed for New Zealand to avoid a last-chance tournament in
Sharie Fleishman
12:20
Gold price sticks to modest gains; upside seems limited amid USD dip-buying
Gold price (XAU/USD) struggles to capitalize on last week's modest recovery from a one-month trough and oscillates in a range
Margarete Antes
12:20
Mainland China, Hong Kong, Macau companies triumph at finale of 2024 PropertyGuru Asia Property Awards
ZHUHAI HUAFA PROPERTIES CO., LTD. LEAD AWARD-WINNING DEVELOPERS AND DESIGN PRACTICES IN THE PROPERTYGURU ASIA PROPERTY AWARDS GRAND FINALHONG KONG,
AFP
12:20
Asian markets track Wall St rally as US inflation eases rate worries
Asian markets rose Monday after big gains on Wall Street, with traders welcoming below-forecast US inflation data that tempered worries
Zonia Howe
12:20
Asia shares rally on US inflation relief
Asia shares rally on US inflation relief
RTTNews
12:19
VINCI Gets Contract To Upgrade Wastewater Treatment Facilities In Canberra, Australia
RTTNews) - VINCI (VCISY.PK) said, Icon Water, the Australian Capital Territory's supplier of water and wastewater services, has awarded Seymour
Barchart
12:19
Stocks Rally on Dovish PCE Inflation Report
The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +1.30%, the Dow Jones Industrials Index ($DOWI )
RTTNews
12:19
AstraZeneca’s Tagrisso Gets EU Approval For Unresectable EGFR-mutated Lung Cancer
RTTNews) - British drug maker AstraZeneca Plc (AZN.L, AZN) announced Monday that the European Commission has approved Tagrisso (osimertinib) to
